440 related articles for article (PubMed ID: 12137611)
1. Exercise for preventing and treating osteoporosis in postmenopausal women.
Bonaiuti D; Shea B; Iovine R; Negrini S; Robinson V; Kemper HC; Wells G; Tugwell P; Cranney A
Cochrane Database Syst Rev; 2002; (3):CD000333. PubMed ID: 12137611
[TBL] [Abstract][Full Text] [Related]
2. Exercise for preventing and treating osteoporosis in postmenopausal women.
Howe TE; Shea B; Dawson LJ; Downie F; Murray A; Ross C; Harbour RT; Caldwell LM; Creed G
Cochrane Database Syst Rev; 2011 Jul; (7):CD000333. PubMed ID: 21735380
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.
Martyn-St James M; Carroll S
Bone; 2008 Sep; 43(3):521-31. PubMed ID: 18602880
[TBL] [Abstract][Full Text] [Related]
5. Fluoride for treating postmenopausal osteoporosis.
Haguenauer D; Welch V; Shea B; Tugwell P; Wells G
Cochrane Database Syst Rev; 2000; 2000(4):CD002825. PubMed ID: 11034769
[TBL] [Abstract][Full Text] [Related]
6. Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis.
Haguenauer D; Welch V; Shea B; Tugwell P; Adachi JD; Wells G
Osteoporos Int; 2000; 11(9):727-38. PubMed ID: 11148800
[TBL] [Abstract][Full Text] [Related]
7. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.
Cranney A; Welch V; Adachi JD; Homik J; Shea B; Suarez-Almazor ME; Tugwell P; Wells G
Cochrane Database Syst Rev; 2000; 2000(2):CD001983. PubMed ID: 10796457
[TBL] [Abstract][Full Text] [Related]
9. Calcium supplementation on bone loss in postmenopausal women.
Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
Cochrane Database Syst Rev; 2003; (4):CD004526. PubMed ID: 14584022
[TBL] [Abstract][Full Text] [Related]
10. Calcium supplementation on bone loss in postmenopausal women.
Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
Cochrane Database Syst Rev; 2004; (1):CD004526. PubMed ID: 14974070
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Combined Exercise Interventions for Preventing Postmenopausal Bone Loss: A Systematic Review and Meta-analysis.
Zhao R; Zhang M; Zhang Q
J Orthop Sports Phys Ther; 2017 Apr; 47(4):241-251. PubMed ID: 28257620
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes.
Martyn-St James M; Carroll S
Br J Sports Med; 2009 Dec; 43(12):898-908. PubMed ID: 18981037
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Brenckmann C; Papaioannou A
Cochrane Database Syst Rev; 2001; (4):CD002010. PubMed ID: 11687132
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous electrical nerve stimulation for knee osteoarthritis.
Osiri M; Welch V; Brosseau L; Shea B; McGowan J; Tugwell P; Wells G
Cochrane Database Syst Rev; 2000; (4):CD002823. PubMed ID: 11034768
[TBL] [Abstract][Full Text] [Related]
15. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
Cochrane Database Syst Rev; 2008 Jan; (1):CD001155. PubMed ID: 18253985
[TBL] [Abstract][Full Text] [Related]
16. Progressive high-intensity resistance training and bone mineral density changes among premenopausal women: evidence of discordant site-specific skeletal effects.
Martyn-St James M; Carroll S
Sports Med; 2006; 36(8):683-704. PubMed ID: 16869710
[TBL] [Abstract][Full Text] [Related]
17. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G;
Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
Avenell A; Gillespie WJ; Gillespie LD; O'Connell DL
Cochrane Database Syst Rev; 2005 Jul; (3):CD000227. PubMed ID: 16034849
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates for steroid induced osteoporosis.
Homik J; Cranney A; Shea B; Tugwell P; Wells G; Adachi R; Suarez-Almazor M
Cochrane Database Syst Rev; 2000; (2):CD001347. PubMed ID: 10796432
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women.
Bilek LD; Waltman NL; Lappe JM; Kupzyk KA; Mack LR; Cullen DM; Berg K; Langel M; Meisinger M; Portelli-Trinidad A; Lang M
BMC Womens Health; 2016 Aug; 16(1):59. PubMed ID: 27576310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
